Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Stabilisation Notice

25 Nov 2020 14:22

RNS Number : 5175G
Morgan Stanley & Co. Int'l plc
25 November 2020
 

 

25 November 2020

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Permanent TSB Group Holdings p.l.c.

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 18 November 2020, Morgan Stanley entity acting as Coordinating Stabilisation Manager (contact: Matteo Benedetto; telephone: 442076773409) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

 

Issuer:

Permanent TSB Group Holdings p.l.c.

Guarantor (if any):

N/A

ISIN:

XS2258541734

Aggregate nominal amount:

EUR 125,000,000

Description:

EUR 125,000,000 Fixed Rate Reset Additional Tier 1 Perpetual Contingent Temporary Write Down Securities

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

Goldman Sachs International

J&E Davy

NatWest Markets Plc

Offer price:

100%

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STABABITMTTTBMM
Date   Source Headline
26th Nov 20203:30 pmRNSDirector Declaration
25th Nov 20202:22 pmRNSStabilisation Notice
18th Nov 20209:10 amRNSStabilisation Notice
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
12th Oct 20202:00 pmRNSDirector Declaration
29th Sep 20204:30 pmRNSAppointment of Senior Independent Director
25th Sep 202010:00 amRNSAppointment of Interim CFO
12th Aug 20204:00 pmRNSDirector/PDMR Shareholding
5th Aug 20203:00 pmRNSDirectorate Change
5th Aug 20203:00 pmRNSResult of AGM
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
6th Jul 202012:00 pmRNSNotice of AGM
6th Jul 202012:00 pmRNSEuronext Listing Rules 6.1.82(1) & (2) Disclosure
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
20th Mar 202012:00 pmRNSConvening of Annual General Meeting Deferred
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSAnnual Financial Report
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:37 pmRNSPrice Monitoring Extension
28th Jan 20204:00 pmRNSDirectorate Change
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20194:00 pmRNSDirector Declaration
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
2nd Oct 201910:00 amRNSDirector Declaration
26th Sep 201912:27 pmRNSStabilisation Notice
24th Sep 20193:30 pmRNSDirectorate Changes
19th Sep 20195:00 pmRNSDirector Declaration
19th Sep 201911:17 amRNSStabilisation Notice
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
6th Aug 20194:00 pmRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
14th May 20194:30 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Update
29th Mar 20193:30 pmRNSNotice of AGM
27th Feb 20197:00 amRNSAnnual Financial Report
27th Feb 20197:00 amRNS2018 Full Year Report Commentary
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.